Mehmet KAPLAN, İbrahim Halil KURT, Alaa QUİSİ, Gökhan ALICI, Şerafettin DEMİR, Fethi YAVUZ, Yurdaer DÖNMEZ
The European Research Journal
2021-Cilt: 7 - Sayı: 1
12-21
high-dose, glycoprotein IIb/IIIa receptor inhibitor, tirofiban, ST-segment elevation myocardial infarction, efficacy, safety
84 89